Exercise and Diet Effects in Reducing Cardiovascular Risk in Kidney Transplant Recipients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-69
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

The goal of this clinical trial is to assess whether, over an observation period of 3 years, there is a reduction in cardiovascular risk, and the extent of this reduction, in a group of adult kidney transplant patients undergoing tailored exercise combined with dietary counselling compared to a group of patients following the 'standard of care'.

Eligibility criteria

Qualifiers

Clinically stabilised male and female kidney transplant patients (assessment by the referring transplant centre)

Minimum age, 30 years;

Maximum age, 69 years;

Period since transplantation: from 6 months (subject to clinical stability being achieved) to 10 years;

Disqualifiers

Patients unable to follow the prescription,

Recent acute cardiovascular event (< 2 months),

Unstable angina,

Hyperkinetic/hypokinetic arrhythmias not controlled by therapy, and with signs of haemodynamic impairment,

Trial design

Treatments tested in this trial

  • lifestyle intervention

Treatment groups

275 Participants
are divided into 2 treatment groups

Sponsors and collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

CNT (Centro Nazionale Trapianti)

Collaborator

Azienda Unità Sanitaria Locale della Romagna

Collaborator